CYP2C19 and acute coronary syndrome: 78 Klein Klein MD MD Williams Williams AK AK Lee Lee CR CR Stouffer Stouffer GA GA Clinical Utility of CYP2C19 Genotyping to Guide Antiplatelet Therapy in Patients With an Acute Coronary Syndrome or Undergoing Percutaneous Coronary Intervention Clinical Utility of CYP2C19 Genotyping to Guide Antiplatelet Therapy in Patients With an Acute Coronary Syndrome or Undergoing Percutaneous Coronary Intervention Arterioscler Thromb Vasc Biol Arterioscler Thromb Vasc Biol 2019 2019 39 39 4 4 647 647 652 652 30760018 30760018 78.